<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lyon GJ</submitter><funding>Research Council of Norway</funding><funding>Departamento de Desarrollo Económico del Gobierno de Navarra</funding><funding>Ministerio Español de Economía y Competitividad Torres Quevedo Program</funding><funding>NIGMS NIH HHS</funding><funding>NIGMS</funding><pagination>e0301328</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11075865</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(5)</volume><pubmed_abstract>Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting approximately 80% of all human proteins. The human essential X-linked gene, NAA10, encodes for the enzyme NAA10, which is the catalytic subunit in the N-terminal acetyltransferase A (NatA) complex. There is extensive genetic variation in humans with missense, splice-site, and C-terminal frameshift variants in NAA10. In mice, Naa10 is not an essential gene, as there exists a paralogous gene, Naa12, that substantially rescues Naa10 knockout mice from embryonic lethality, whereas double knockouts (Naa10-/Y Naa12-/-) are embryonic lethal. However, the phenotypic variability in the mice is nonetheless quite extensive, including piebaldism, skeletal defects, small size, hydrocephaly, hydronephrosis, and neonatal l</pubmed_abstract><journal>PloS one</journal><pubmed_title>Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.</pubmed_title><pmcid>PMC11075865</pmcid><funding_grant_id>PTQ-13-06466</funding_grant_id><funding_grant_id>R35-GM-133408</funding_grant_id><funding_grant_id>0011-1383-2018-000011</funding_grant_id><funding_grant_id>249843</funding_grant_id><funding_grant_id>R35 GM133408</funding_grant_id><pubmed_authors>Lyon GJ</pubmed_authors><pubmed_authors>Nashat MA</pubmed_authors><pubmed_authors>Inusa F</pubmed_authors><pubmed_authors>Garcia A</pubmed_authors><pubmed_authors>Marchi E</pubmed_authors><pubmed_authors>Arnesen T</pubmed_authors><pubmed_authors>Lyons S</pubmed_authors><pubmed_authors>Shi D</pubmed_authors><pubmed_authors>Dorfel M</pubmed_authors><pubmed_authors>Aldabe R</pubmed_authors><pubmed_authors>Bolton D</pubmed_authors><pubmed_authors>Longo J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.</name><description>Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting approximately 80% of all human proteins. The human essential X-linked gene, NAA10, encodes for the enzyme NAA10, which is the catalytic subunit in the N-terminal acetyltransferase A (NatA) complex. There is extensive genetic variation in humans with missense, splice-site, and C-terminal frameshift variants in NAA10. In mice, Naa10 is not an essential gene, as there exists a paralogous gene, Naa12, that substantially rescues Naa10 knockout mice from embryonic lethality, whereas double knockouts (Naa10-/Y Naa12-/-) are embryonic lethal. However, the phenotypic variability in the mice is nonetheless quite extensive, including piebaldism, skeletal defects, small size, hydrocephaly, hydronephrosis, and neonatal l</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-01T17:26:56.065Z</modification><creation>2026-04-08T14:14:33.438Z</creation></dates><accession>S-EPMC11075865</accession><cross_references><pubmed>38713657</pubmed><doi>10.1371/journal.pone.0301328</doi></cross_references></HashMap>